NTRK1 and gastrointestinal stromal tumor: We are thus convinced that the findings described herein will not only guide the design and the development of next-generation inhibitors to overcome toxicity-associated brain permeability and the current landscape of resistance mutations in GIST but will also have an impact on other cancers where mutated receptor tyrosine kinases are oncogenic drivers.